. Author manuscript; available in PMC: 2010 Feb 1.

Published in final edited form as: Neuropsychopharmacology. 2009 Apr 22;34(9):2143–2155. doi: 10.1038/npp.2009.40

Table 3.

Effects of Sp-cAMPS on performance on the variable-short inter-trial interval version of the 5CSRTT

	Vehicle				Sp-cAMPS (2.1 nmol/0.5 μl/side)

	0.5-s	1.5-s	3.0-s	4.5-s	0.5-s	1.5-s	3.0-s	4.5-s

% Accuracy	48.4 ± 8.0	67.1 ± 3.9^*	67.5 ± 5.8^*	72.9 ± 4.9^*	53.6 ± 6.3	73.4 ± 3.1^*	80.0 ± 3.4^*	74.1 ± 3.4^*
% Omissions	60.0 ± 6.2	39.1 ± 6.5^*	20.3 ± 5.3^*	13.6 ± 4.8^*	55.2 ± 4.4	38.2 ± 4.6^*	25.2 ± 5.8^*	23.0 ± 6.3^*

Note: There was an ITI duration-dependent effect on both accuracy and omissions whereby accuracy was impaired at the shortest ITI (0.5-s) and omissions were increased at the shortest ITI compared to the longer ITIs, but Sp-cAMPS did not further affect performance at any ITI.

P<0.05, within-subjects comparison.